Menu

Update

Register: “The In Utero Environment, Cancer Over the Life-course & Relevance to Current Trends in Cancer Incidence”

Close up of a pregnant person holding their belly

Webinar Discussion: The In Utero Environment, Cancer Over the Life-course & Relevance to Current Trends in Cancer Incidence: Direct Evidence From a 60-year Follow-up of the Child Health and Development Studies Cohort

Tuesday, October 26
12 pm – 1 pm PT | 3 pm – 4 pm ET

Register

 

PHI’s Child Health and Development Studies (CHDS) is a three-generation research study that explores the relation of perinatal events and environmental chemical exposures to cancer in mothers, sons and daughters and recently to cancer risk factors in granddaughters. These are some of the first studies ever to report on the relation of in utero exposures to cancer risk and to consider the importance of exposure timing during windows of susceptibility.

Dr. Cohn, CHDS director, will summarize published studies on breast cancer, testes cancer, and new findings on early onset colon cancer and our newest funding and approach for investigation of two-generation risk for lethal prostate cancer with a focus on disparate higher risk for aggressive disease in Black men. She will also present metabolomics findings relevant to uncovering mechanisms observed for patterns of cancer risk in the Child Health and Development Studies cohort and discuss her view of next steps for life-course studies of cancer.

This webinar is part of the NIH Environmental Epidemiology Webinar Series, which explores novel cancer research strategies and research needs focused on the exposome and early-life environmental exposures and events.

Barbara Cohn

Dr. Barbara Cohn, Director, PHI's Child Health and Development Studies

Barbara A. Cohn, PhD, is director of the Child Health and Development Studies (CHDS) at PHI. CHDS is home to a groundbreaking study, which originated in 1959, designed to shed light on the various factors impacting health during pregnancy and early childhood. Between 1959 and 1967, 15,000 pregnant women and their families were enrolled. Researchers continue to study these rich data and conduct important follow-up studies to further examine how events during pregnancy impact the subsequent health of fathers, mothers and their children and grandchildren. Cohn consults with researchers around the world on the use of the CHDS data and conducts critical health research.

Learn more about Dr. Cohn


More Updates

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Close

Breakthrough Infection Study of Over 600,000 Veterans Shows Declining COVID-19 Vaccine Protection

A new pre-print study of over 600,000 veterans by researchers from PHI and the Veterans Affairs Medical Center finds that overall COVID-19 vaccine protection declined significantly between February and August 2021. Declines were greatest for the Johnson & Johnson vaccine (from 88% in March to 3% in August), followed by PfizerBioNTech (91% to 50%) and Moderna (92% to 64%).

More

Continue to PHI.org